1
Clinical Trials associated with Autologous Fat Pad Derived Mesenchymal Stem Cells(The Methodist Hospital Research Institute) / Not yet recruitingPhase 1IIT Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells
This study is designed as a prospective, open label, single arm pilot clinical study that will establish the safety and efficacy of a single injection of mesenchymal stromal cells in patients. Each subject will receive one intra-articular injection of autologous mesenchymal stromal cells derived from infrapatellar fat pad (FP-MSC) tissue samples collected from the subject during anterior cruciate ligament (ACL) reconstruction surgery.
100 Clinical Results associated with Autologous Fat Pad Derived Mesenchymal Stem Cells(The Methodist Hospital Research Institute)
100 Translational Medicine associated with Autologous Fat Pad Derived Mesenchymal Stem Cells(The Methodist Hospital Research Institute)
100 Patents (Medical) associated with Autologous Fat Pad Derived Mesenchymal Stem Cells(The Methodist Hospital Research Institute)
100 Deals associated with Autologous Fat Pad Derived Mesenchymal Stem Cells(The Methodist Hospital Research Institute)